GTCR Acquires XIFIN
Chicago, IL and San Diego, CA — July 30, 2014 — GTCR, a leading private equity firm, today announced that it has acquired XIFIN, Inc. (“XIFIN” or “the Company”). XIFIN, headquartered in San Diego, California, is a leading provider of cloud-based software and services to diagnostic service providers. XIFIN’s technology platform enables end-to-end connectivity from patient to payor, linking together the many stakeholders in healthcare delivery and optimizing for the best business and patient outcomes.
“We believe XIFIN’s leading position, market expertise and best-in-class technology provide a unique value proposition to laboratories as they navigate a complex reimbursement and regulatory environment. GTCR looks forward to investing in the business and building a leading company within the healthcare information technology industry.”
Since its founding, XIFIN’s technology solutions have supported some of the nation’s largest and most complex diagnostics providers. The Company’s customers occupy a diverse set of industry segments, including molecular diagnostics, pain management/toxicology, anatomic pathology, radiology, hospital outreach, medical device and clinical laboratories. Built on a secure, web services-based technology platform, XIFIN’s core product is a cloud-based workflow application designed to help clients optimize billing and collection practices, automate billing workflow and reduce regulatory compliance risk. XIFIN’s health economics optimization platform also includes additional cloud-based applications, including a Laboratory Information System, physician and patient portals, enterprise class business intelligence and a physician collaboration network. By bringing together financial and clinical information and combining with advanced business intelligence, XIFIN aims to provide diagnostic service providers the ability to lower healthcare costs while improving patient outcomes.
As part of the transaction, GTCR will partner with founder and CEO Lâle White and the management team at XIFIN as they continue to grow and develop the Company’s services and product offering. An accomplished industry veteran, Ms. White has built XIFIN into a market leading solution for complex laboratory business operations.
“We are excited to partner with Lâle and her team to acquire XIFIN,” said Dean Mihas, Managing Director at GTCR. “We believe XIFIN’s leading position, market expertise and best-in-class technology provide a unique value proposition to laboratories as they navigate a complex reimbursement and regulatory environment. GTCR looks forward to investing in the business and building a leading company within the healthcare information technology industry.”
“GTCR is a great partner for XIFIN,” stated Lâle White. “They have tremendous capital resources and a proven history of building market-leading companies. GTCR shares our commitment to delivering health optimization solutions and services to the diagnostic service provider market, and we will benefit immensely from GTCR’s resources. XIFIN remains deeply committed to the markets we serve, and in expanding our investment in our customers, technology platform solutions and employees.”
Ben Daverman, Vice President at GTCR, added: “The acquisition of XIFIN underscores GTCR’s extensive experience and track record in healthcare, information technology and financial services. Our history of successful investments in diagnostic laboratories and SaaS-based software providers will enable us to help fuel the next phase of XIFIN’s growth.”
GTCR’s investment in XIFIN was funded from GTCR Fund XI, a private equity fund raised in 2014 with $3.85 billion of limited partner equity capital commitments. GE Capital and CapitalSource provided financing for the transaction. Kirkland & Ellis LLP served as legal counsel to GTCR.
